To include your compound in the COVID-19 Resource Center, submit it here.

Ozurdex dexamethasone intravitreal implant regulatory update

The U.K.'s NICE issued a final appraisal determination (FAD) recommending use of Allergan's Ozurdex dexamethasone intravitreal implant to treat macular edema following central

Read the full 235 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE